Research Proves Natural Movement Of Disease
Resistance Genes And The Potential Benefit Of Precise Gene Editing
Technology To Support Sustainability Practices And Improve Farmer
Yields
INDIANAPOLIS, June 12,
2023 /PRNewswire/ -- Corteva Agriscience (NYSE: CTVA)
today announced publication of research confirming the natural
movement of disease resistance genes within a corn plant's genome.
The research has implications for the application of new breeding
techniques to reduce the devastating impact of plant diseases while
improving yield potential and crop resilience. Published in a
recent issue of Molecular Plant Pathology, the
findings reveal that gene editing tools such as CRISPR can mimic
this naturally occurring process, unlocking the ability to relocate
multiple disease resistance genes, speeding plant breeding
progress, and delivering enhanced high-performing products to
farmers.
![(PRNewsfoto/DowDuPont) (PRNewsfoto/DowDuPont)](https://mma.prnewswire.com/media/880919/Corteva_Logo.jpg)
In March, Corteva announced that the early-stage use of
proprietary gene editing technology to address several North
American corn diseases was advancing through the company's R&D
pipeline. Using CRISPR, the company can precisely co-locate disease
resistance traits that already exist within the corn genome. With
this recent peer-reviewed research, Corteva demonstrates that
disease resistance genes move naturally to help plants fend off
attacks from pathogens - but do so very slowly.
"A plant deals with a wide variety of pathogens, prompting its
genes to naturally move around in the genome to resist disease and
increase survivability," said Wendy
Srnic, Vice President Biotechnology, Corteva Agriscience.
"However, this natural gene mobility occurs too slowly to
effectively address the rapid growth of disease and climate-related
pressures facing farmers around the globe. Through our research, we
have validated the ability to mirror the movement of genes,
enabling us to apply new breeding techniques to deliver seed that
can better withstand field-level challenges."
In 2021, Northern leaf blight, Southern rust, gray leaf spot and
anthracnose stalk rot combined to cost North America corn growers more than 318
million bushels in production. By leveraging new breeding
techniques, Corteva is not only simplifying disease management
options for farmers but also improving on-farm sustainability by
reducing the need for additional crop protection product
applications to help combat disease pressure.
"By innovating with advanced breeding techniques, we aim to
create transformational change," added Srnic. "With these
techniques, we can harness and replicate naturally occurring
processes that accelerate the development of seeds with improved
resilience and yield. We are committed to giving farmers more
planting choices while continuing to safeguard our natural
resources for generations to come."
About Corteva Agriscience
Corteva, Inc. (NYSE: CTVA)
is a publicly traded, global pure-play agriculture company that
combines industry-leading innovation, high-touch customer
engagement and operational execution to profitably deliver
solutions for the world's most pressing agriculture challenges.
Corteva generates advantaged market preference through its unique
distribution strategy, together with its balanced and globally
diverse mix of seed, crop protection, and digital products and
services. With some of the most recognized brands in agriculture
and a technology pipeline well positioned to drive growth, the
company is committed to maximizing productivity for farmers, while
working with stakeholders throughout the food system as it fulfills
its promise to enrich the lives of those who produce and those who
consume, ensuring progress for generations to come. More
information can be found at www.corteva.com. Follow Corteva
on Facebook, Instagram, LinkedIn, Twitter,
and YouTube.
Cautionary Statement on Forward-Looking
Statements
This release contains certain forward-looking
statements within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended, and Section 27A of the Securities
Act of 1933, as amended, which are intended to be covered by the
safe harbor provisions for forward-looking statements contained in
the Private Securities Litigation Reform Act of 1995, and may be
identified by their use of words like "plans," "expects," "will,"
"anticipates," "believes," "intends," or other words of similar
meaning. All statements that address expectations or projections
about the future, including statements about Corteva's expectations
related to regulatory approvals, product development, product
offerings and product, financial or sustainability performance are
forward-looking statements. Corteva disclaims and does not
undertake any obligation to update or revise any forward-looking
statement, except as required by applicable law. A detailed
discussion of some of the significant risks and uncertainties which
may cause results and events to differ materially from such
forward-looking statements or other estimates is included in the
"Risk Factors" section of Corteva's Annual Report on Form 10-K, as
modified by subsequent reports on Form 10-Q and Current Reports on
Form 8-K.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/corteva-agriscience-harnesses-nature-to-unlock-plant-disease-resistance-301845520.html
SOURCE Corteva, Inc.